福森药业有限公司（01652）于2025年12月1日发布2025年11月的股份变动月报表。公告显示，公司本月股本结构维持稳定，未见新增发行或购回注销活动。
公司注册股本维持于2,000,000,000股，面值为每股0.01港元，注册股本总额为20,000,000港元。报告期末已发行股份总数为739,301,000股，与上月底一致；未设立或持有任何库存股份。
根据公告，福森药业目前仍保留于2018年6月14日授出的购股权计划，涉及16,000,000份未行使期权。截至11月底，该计划未有新股发行或期权行使，期权授出数量、失效及行使情况均无变化。
公司声明已遵守香港联交所《上市规则》及相关法律规定，并确认本月所有股份及期权事宜均经董事会正式授权批准。公告由公司秘书杨育康签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.